Successful treatment with leukocytapheresis in refractory Henoch-Schönlein purpura: Case report

Clinical Rheumatology

Volumn 22, Issue 3, 2003, Pages 248-250

  Nakahata, Tohru ^a   Tanaka, Hiroshi ^a   Suzuki, Koichi ^a   Ito, Etsuro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Henoch Sch nlein purpura; Leukocytapheresis; Severe abdominal pain; Steroid resistant

Indexed keywords

BLOOD CLOTTING FACTOR 13; DEXAMETHASONE; INTERLEUKIN 6; NAFAMSTAT MESILATE; PREDNISOLONE;

ABDOMINAL PAIN; ANAPHYLACTOID PURPURA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL OBSERVATION; COLIC; DIARRHEA; DISEASE SEVERITY; HUMAN; LABORATORY TEST; LEUKAPHERESIS; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; SCHOOL CHILD; SKIN BIOPSY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

CHILD; DEXAMETHASONE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LEUKAPHERESIS; MALE; PREDNISOLONE; PURPURA, SCHOENLEIN-HENOCH; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0141997216     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0695-9     Document Type: Article

References (14)

1. Schaller JG (1996) Henoch-Schönlein purpura or vasculitis. Nelson Textbook of Pediatrics, 15th ed. W.B. Saunders Company, Philadelphia, 677-678
2. Rosenblum ND, Winter HS (1987) Steroid effects on the course of abdominal pain in children with Henoch-Schönlein purpura. Pediatrics 79: 1018-1021
3. Pyne D, Mootoo R, Bhanji A (2001) Colchicine for the treatment of recurrent Henoch-Schönlein purpura in an adult. Rheumatology 40: 1430-1431
4. Ulsben M (1996) Inflammatory bowel disease. Nelson Textbook of Pediatrics, 15th ed. W.B. Saunders Company, Philadelphia, 1080-1087
5. Sawada K, Ohnishi K, Fukui S, Yamada K, Yamamura M, Amano K, et al. (1995) Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease. J Gastroenterol 30: 322-329
6. Cassidy JT, Petty RE (2001) Textbook of Pediatric Rheumatology. 4th ed. W.B. Saunders Company, Philadelphia, 569-574
7. Kamitsuji H, Tani K, Yasuif A, Taniguchi A, Taira K, Iida Y, et al. (1987) Activity of blood coagulation Factor XIII as prognostic indicator in patients with Henoch-Schönlein purpura: efficacy of Factor XIII substitution. Eur J Pediatr 146: 519-523
8. Utani A, Ohta M, Shinya A, Ohno S, Takakuwa H, Yamamoto T, et al. (1991) Successful treatment of adult Henoch-Schönlein purpura with factor XIII concentrate. J Am Acad Dermatol 24: 438-442
9. Hidaka T, Suzuki K (1997) Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis. Ther Apher 1: 212-214
10. Yajima T, Takaishi H, Kanai T, Iwao Y, Watanabe M, Ishii H, et al. (1998) Predictive factors of response to leukocytapheresis therapy for ulcerative colitis. Ther Apher 2: 115-119
11. Sawada K, Ohnishi K, Kosaka T, Chikano S, Yokota Y, Egashira A, et al. (1997) Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1: 207-211
12. Sawada K, Shimoyama T (1998) Therapeutic cytapheresis for inflammatory bowel disease. Ther Apher 2: 90-92
13. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, et al. (1997) The role of cytokines in Henoch-Schönlein purpura. Scand J Rheumatol 26: 456-460
14. Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, et al. (1988) Differences in tumor necrosis factor-α soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: Pathogenetic implications. J Rheumatol 25: 361-365